Conduit Pharmaceuticals I...

2.36
0.81 (52.26%)
At close: Feb 07, 2025, 3:59 PM
2.34
-0.85%
After-hours Feb 07, 2025, 07:59 PM EST
undefined%
Bid 2.33
Market Cap 5.01M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -23
PE Ratio (ttm) -0.1
Forward PE n/a
Analyst n/a
Ask 2.4
Volume 142,911,639
Avg. Volume (20D) 670,836
Open 2.67
Previous Close 1.55
Day's Range 2.25 - 3.70
52-Week Range 1.45 - 392.00
Beta undefined

About CDT

Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California...

Industry Biotechnology
Sector Healthcare
IPO Date Mar 28, 2022
Employees 7
Stock Exchange NASDAQ
Ticker Symbol CDT
2 days ago
+83.87%
Conduit Pharmaceuticals shares are trading higher ... Unlock content with Pro Subscription
2 weeks ago
-20%
Conduit Pharmaceuticals shares are trading lower after the company board approved a 1-for-100 reverse stock split.